M. Egawa, M. Fukuda, H. Takashima, T. Misaki, K. Kinuya et al., The sentinel node concept in prostate cancer: Present reality and future prospects, Indian Journal of Urology, vol.24, issue.4, pp.451-457, 2008.
DOI : 10.4103/0970-1591.44246

B. Kiss, H. Thoeny, and U. Studer, Current Status of Lymph Node Imaging in Bladder and Prostate Cancer, Urology, vol.96, pp.1-7
DOI : 10.1016/j.urology.2016.02.014

J. Jakobsen, Sentinel node biopsy in uro-oncology: A history of the development of a promising concept, Urologic Oncology: Seminars and Original Investigations, vol.33, issue.11, pp.486-93, 2015.
DOI : 10.1016/j.urolonc.2015.08.010

R. Cabanas, An approach for the treatment of penile carcinoma, Cancer, vol.15, issue.2, pp.456-66, 1977.
DOI : 10.1148/79.2.209

F. Wawroschek, H. Vogt, D. Weckermann, T. Wagner, and R. Harzmann, The Sentinel Lymph Node Concept in Prostate Cancer – First Results of Gamma Probe-Guided Sentinel Lymph Node Identification, European Urology, vol.36, issue.6, pp.595-600, 1999.
DOI : 10.1159/000020054

M. A. Pillai, F. Knapp, and 2. Doi, Overcoming the 99mTc shortage: are options being overlooked?, J Nucl Med, vol.52, issue.2, pp.15-16, 2011.

I. Stoffels, J. Dissemond, T. Pöppel, D. Schadendorf, and J. Klode, Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes, 2015.

S. Inoue, H. Shiina, N. Arichi, Y. Mitsui, T. Hiraoka et al., Identification of lymphatic pathway involved in the spreading of prostate cancer by fluorescence navigation approach with intraoperatively injected indocyanine green, J Can Urol Assoc, 2011.

A. Winter, J. Woenkhaus, and F. Wawroschek, A Novel Method for Intraoperative Sentinel Lymph Node Detection in Prostate Cancer Patients Using Superparamagnetic Iron Oxide Nanoparticles and a Handheld Magnetometer: The Initial Clinical Experience, Annals of Surgical Oncology, vol.18, issue.7, pp.4390-4396, 2014.
DOI : 10.1245/s10434-011-1710-7

A. Häcker, S. Jeschke, K. Leeb, K. Prammer, J. Ziegerhofer et al., Detection of Pelvic Lymph Node Metastases in Patients With Clinically Localized Prostate Cancer: Comparison of [18F]Fluorocholine Positron Emission Tomography-Computerized Tomography and Laparoscopic Radioisotope Guided Sentinel Lymph Node Dissection, The Journal of Urology, vol.176, issue.5, pp.2014-2022, 2006.
DOI : 10.1016/j.juro.2006.07.037

S. Jeschke, A. Beri, M. Grüll, J. Ziegerhofer, P. Prammer et al., Laparoscopic Radioisotope-Guided Sentinel Lymph Node Dissection in Staging of Prostate Cancer, European Urology, vol.53, issue.1, pp.126-159, 2008.
DOI : 10.1016/j.eururo.2007.03.064

D. Weckermann, G. Holl, R. Dorn, T. Wagner, and R. Harzmann, Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer, BJU International, vol.49, issue.5
DOI : 10.1097/01.ju.0000158159.16314.eb

S. Warncke, A. Mattei, F. Fuechsel, Z. Brun, S. Krause et al., Detection Rate and Operating Time Required for ?? Probe-Guided Sentinel Lymph Node Resection after Injection of Technetium-99m Nanocolloid into the Prostate with and without Preoperative Imaging, European Urology, vol.52, issue.1, pp.126-159, 2007.
DOI : 10.1016/j.eururo.2007.01.050

Y. Zhu, Y. Sun, Y. Chen, W. Liu, J. Jiang et al., In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles, International Journal of Molecular Sciences, vol.19, issue.5, pp.9573-87, 2015.
DOI : 10.1002/smll.201100472

M. Harisinghani, J. Barentsz, P. Hahn, W. Deserno, S. Tabatabaei et al., Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer, New England Journal of Medicine, vol.348, issue.25, pp.2491-2500, 2003.
DOI : 10.1056/NEJMoa022749

L. Vermeeren, W. Meinhardt, H. Van-der-poel, V. Olmos, and R. , Lymphatic drainage from the treated versus untreated prostate: feasibility of sentinel node biopsy in recurrent cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.133, issue.11
DOI : 10.1177/153303460700600610

A. Muck, C. Langesberg, M. Mugler, J. Rahnenführer, B. Wullich et al., Clinical Outcome of Patients with Lymph Node-Positive Prostate Cancer following Radical Prostatectomy and Extended Sentinel Lymph Node Dissection, Urologia Internationalis, vol.94, issue.3, pp.296-306, 2014.
DOI : 10.1159/000365011

S. Krumme, PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status, Theranostics, vol.5, pp.1388-401, 2015.

S. Rowe, M. Gorin, M. Allaf, K. Pienta, P. Tran et al., PET imaging of prostatespecific membrane antigen in prostate cancer: current state of the art and future challenges

S. Sankineni, A. Brown, M. Fascelli, Y. Law, P. Pinto et al., Lymph Node Staging in Prostate Cancer, Current Urology Reports, vol.84, issue.5, pp.1-9, 2015.
DOI : 10.1097/01.rmr.0000130602.65243.87

G. Wright, C. Haley, M. Beckett, . Lou, and P. Schellhammer, Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues, Urologic Oncology: Seminars and Original Investigations, vol.1, issue.1, pp.18-28, 1995.
DOI : 10.1016/1078-1439(95)00002-Y

A. Afshar-oromieh, C. Zechmann, A. Malcher, M. Eder, M. Eisenhut et al., Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.82, issue.17, pp.11-20, 2014.
DOI : 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S

L. Budäus, S. Leyh-bannurah, G. Salomon, U. Michl, H. Heinzer et al., Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy, European Urology, vol.69, issue.3
DOI : 10.1016/j.eururo.2015.06.010

T. Maurer, G. Weirich, M. Schottelius, M. Weineisen, B. Frisch et al., Prostate-specific Membrane Antigen???radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer, European Urology, vol.68, issue.3
DOI : 10.1016/j.eururo.2015.04.034

D. Bates, S. Abraham, M. Campbell, I. Zehbe, L. Curiel et al., Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging, PLoS ONE, vol.2, issue.5, 2014.
DOI : 10.1371/journal.pone.0097220.t001